Surgical & Medical Instruments & Apparatus·FRAMINGHAM, MA
Summary Financials
Arch Therapeutics, Inc. — SlamSEC
Revenue
$15,652
+35.3% YoY
FY 2023
Adj. EBITDA
-$5.7M
-36452.9% margin
FY 2023
Net Income
-$5.3M
-33707.2% margin
FY 2023
EPS (Diluted)
-$0.02
FY 2021
Stock Price
—
52W Range
—
P/E Ratio
—
Market Cap
—
Cash
$5.0M
FY 2018
Total Debt
$176,300
FY 2021
Net Cash
$4.9M
FY 2021
Enterprise Value
—
Debt / EBITDA
0.9x
FY 2023
EV / EBITDA
—
Employees
—
An arch is a curved vertical structure spanning an open space underneath it. Arches may support the load above them, or they may perform a purely decorative role.